Literature DB >> 18321879

Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Jordyn L Gamiel1, Aaron A R Tobian, Oliver B Laeyendecker, Steven J Reynolds, Rhoda Ashley Morrow, David Serwadda, Ronald H Gray, Thomas C Quinn.   

Abstract

Ugandan subjects (820) were tested by Focus HerpeSelect enzyme-linked immunosorbent assay (ELISA), Kalon herpes simplex virus type 2 ELISA, and BioKit rapid test, and the results were compared to those of Western blotting. Higher-than-standard-index cutoff values gave optimal sensitivity and specificity. Kalon ELISA was the optimal assay when an index value of 1.5 was used (sensitivity, 91.7%; specificity, 92.4%).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18321879      PMCID： PMC2394849          DOI： 10.1128/CVI.00453-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  17 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.

Authors:  Mabula Joseph Kasubi; Arvid Nilsen; Howard S Marsden; Tomas Bergström; Nina Langeland; Lars Haarr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Genital herpes and public health: addressing a global problem.

Authors:  L Corey; H H Handsfield
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 4.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

5.  Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Authors:  Staffan Görander; Judica Mbwana; Eligius Lyamuya; Teresa Lagergård; Jan-Ake Liljeqvist
Journal:  Clin Vaccine Immunol       Date:  2006-06

6.  Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors:  Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.

Authors:  R Ashley-Morrow; J Nollkamper; N J Robinson; N Bishop; J Smith
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

8.  Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors:  Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 9.  The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.

Authors:  Lawrence Corey; Anna Wald; Connie L Celum; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2004-04-15       Impact factor: 3.731

10.  Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.

Authors:  David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer
Journal:  J Infect Dis       Date:  2003-10-28       Impact factor: 5.226
View more
  31 in total

1.  Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Andrew D Redd; David Serwadda; Xiangrong Kong; Amy Oliver; Fred Nalugoda; Thomas C Quinn; Ronald H Gray; Maria J Wawer
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Authors:  J Lingappa; E Nakku-Joloba; A Magaret; D Friedrich; J Dragavon; F Kambugu; M Joloba; C Whalen; R Coombs; C Celum; R Ashley Morrow
Journal:  Int J STD AIDS       Date:  2010-09       Impact factor: 1.359

3.  Performance of HSV-2 type specific serological tests in men in Kenya.

Authors:  Musa Otieno Ng'ayo; David Friedrich; King K Holmes; Elizabeth Bukusi; Rhoda Ashley Morrow
Journal:  J Virol Methods       Date:  2009-10-23       Impact factor: 2.014

4.  Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Patti E Gravitt; Changchang Xiao; David Serwadda; Kevin P Eaton; Xiangrong Kong; Maria J Wawer; Fred Nalugoda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

5.  High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda.

Authors:  Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Patti E Gravitt; Kevin P Eaton; David Serwadda; Fred Nalugoda; Maria J Wawer; Thomas C Quinn; Ronald H Gray
Journal:  Sex Transm Infect       Date:  2012-05-24       Impact factor: 3.519

6.  Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Maria J Wawer; David Serwadda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

7.  Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Authors:  Sinéad Delany-Moretlwe; Ute Jentsch; Helen Weiss; Jocelyn Moyes; Rhoda Ashley-Morrow; Wendy Stevens; Philippe Mayaud
Journal:  Sex Transm Infect       Date:  2009-10-16       Impact factor: 3.519

8.  Serologic screening for herpes simplex virus type 2 in persons with human immunodeficiency virus.

Authors:  Nicholas J Van Wagoner; Rhoda Morrow; Jeannette Lee; Paula Dixon; Edward W Hook
Journal:  Am J Med Sci       Date:  2013-08       Impact factor: 2.378

9.  Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin.

Authors:  Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Andrew D Redd; Kevin P Eaton; David Serwadda; Toby C Cornish; Fred Nalugoda; Stephen Watya; Denis Buwembo; James Nkale; Maria J Wawer; Thomas C Quinn; Ronald H Gray
Journal:  J Infect Dis       Date:  2013-01-23       Impact factor: 5.226

10.  Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials.

Authors:  Ronald H Gray; David Serwadda; Aaron A R Tobian; Michael Z Chen; Frederick Makumbi; Tara Suntoke; Godfrey Kigozi; Fred Nalugoda; Boaz Iga; Thomas C Quinn; Lawrence H Moulton; Oliver Laeyendecker; Steven J Reynolds; Xiangrong Kong; Maria J Wawer
Journal:  PLoS Med       Date:  2009-11-24       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.